Found 14 matching trials
Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial PHASE3 This is a randomized, controlled clinical trial based on prior exploratory ...
Show More Location
Guangdong Provincial People's Hospital
Learn More & Join Trial
Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS) N/A The purpose of this clinical trial is to evaluate the impact of early initi...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis PHASE3 Calcific aortic stenosis (CAS) can cause severe adverse cardiac events, but...
Show More Location
Beijing Anzhen Hospital, Capital Medical University
Learn More & Join Trial
PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis PHASE3 Calcific aortic stenosis (CAS) can cause severe adverse cardiac events, but...
Show More Location
Beijing Anzhen Hospital, Capital Medical University
Learn More & Join Trial
Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer PHASE2 Background:
Gastric cancer remains a significant health burden globally, p...
Show More Location
he First Affiliated Hospital, College of Medicine, Zhejiang University
Learn More & Join Trial
PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy PHASE2 This study evaluated the sintilimab combination of bevacizumab and tafoleci...
Show More Location
Multiple Locations
Learn More & Join Trial
Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals N/A This is a prospective, observational cohort study. Patients will be assigne...
Show More Location
Qianfoshan Hospital
Learn More & Join Trial
Bioequivalence Study of Tafolecimab Injections in Chinese Healthy Male Volunteers PHASE1 This trial is conducted in China. The purpose of this study is to evaluate ...
Show More Location
Aerospace Center Hospital
Learn More & Join Trial
A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy. PHASE2 The second-line treatment for patients who have progressed after first-line...
Show More Location
Beijing Chest Hospital, Capital Medical University
Learn More & Join Trial
Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer PHASE2 This is a single arm, multi-center clinical trial. The goal of this clinica...
Show More Location
Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University
Learn More & Join Trial